期刊文献+

Changes in expression of adrenomedullin in the myocardium of streptozotocin-induced diabetic rats 被引量:5

Changes in expression of adrenomedullin in the myocardium of streptozotocin-induced diabetic rats
原文传递
导出
摘要 Background Adrenomedullin is a potent vasodilating peptide and involved in many cardiovascular diseases. However, whether adrenomedullin is involved in the pathogenesis of diabetic cardiomyopathy is still unknown. Our aim was to characterize the expression pattern of adrenomedullin in the myocardium of streptozotocin-induced diabetic rats. Methods The weight, blood glucose, and urine glucose of 20 streptozotocin-induced diabetic rats were measured before and after model induction in the diabetic and control groups. The alteration of the adrenomedullin expression was explored in the left ventricular myocardium in both groups by immunohistochemistry. Changes in heart ultrastructure were also analyzed by using hemotoxylin and eosin staining and transmission electron microscopy. All data were analyzed by the independent samples ttest. Results The data of weight, blood glucose, and urine glucose had no significant difference between the control and the diabetic groups before animal model induction. Four weeks after the induction of diabetes, the differences between the two groups in weight, blood glucose, and urine glucose were distinct. When compared with the control group, the diabetic group showed ultrastructural changes including hypertrophy, fibrosis, myofibrillar disarrangements, mitochondrial disruption, and increase in nuclear membrane invaginations. A significant decrease of adrenomedullin expression was also observed in cardiac myocytes of the diabetic rats (P〈0.01). Conclusions Our study provides experimental evidence that hyperglycemia could damage cardiac myocytes. Down-regulation of cardioprotective peptide adrenomedullin in the myocardium of streptozotocin-induced diabetic rats may contribute to the diabetic cardiomyopathy and left ventricular dysfunction. Background Adrenomedullin is a potent vasodilating peptide and involved in many cardiovascular diseases. However, whether adrenomedullin is involved in the pathogenesis of diabetic cardiomyopathy is still unknown. Our aim was to characterize the expression pattern of adrenomedullin in the myocardium of streptozotocin-induced diabetic rats. Methods The weight, blood glucose, and urine glucose of 20 streptozotocin-induced diabetic rats were measured before and after model induction in the diabetic and control groups. The alteration of the adrenomedullin expression was explored in the left ventricular myocardium in both groups by immunohistochemistry. Changes in heart ultrastructure were also analyzed by using hemotoxylin and eosin staining and transmission electron microscopy. All data were analyzed by the independent samples ttest. Results The data of weight, blood glucose, and urine glucose had no significant difference between the control and the diabetic groups before animal model induction. Four weeks after the induction of diabetes, the differences between the two groups in weight, blood glucose, and urine glucose were distinct. When compared with the control group, the diabetic group showed ultrastructural changes including hypertrophy, fibrosis, myofibrillar disarrangements, mitochondrial disruption, and increase in nuclear membrane invaginations. A significant decrease of adrenomedullin expression was also observed in cardiac myocytes of the diabetic rats (P〈0.01). Conclusions Our study provides experimental evidence that hyperglycemia could damage cardiac myocytes. Down-regulation of cardioprotective peptide adrenomedullin in the myocardium of streptozotocin-induced diabetic rats may contribute to the diabetic cardiomyopathy and left ventricular dysfunction.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2007年第3期187-191,共5页 中华医学杂志(英文版)
基金 the Natural Science Foundation of Zhejiang Province (No.Y204036)
关键词 diabetic cardiomyopathy adrenomeduUin transmission electron microscopy RAT diabetic cardiomyopathy adrenomeduUin transmission electron microscopy rat
  • 相关文献

参考文献1

二级参考文献14

  • 1Yoshibayashi M;Kamiya T;KITAMURA K.Plasma levels of adrenomedullin in primary and secondary pulmonary hypertension in patients <20 years of age,1997.
  • 2Yoshihara F;Nishikimi T;Horio T.Chronic infusion of adrenomedullin reduces pulmonary hypertension and lessens right ventricular hypertrophy in rats administered monocrotaline[J],1998(1).
  • 3Horio T;Kohno M;Kano H.Adrenomedullin as a novel antimigration factor of vascular smooth muscle cells,1995.
  • 4ZHAO L;Brown LA;Owji AA.Adrenomedulin activity in chronically hypoxic rat lungs,1996.
  • 5Horio T;Nishikimi T;Yoshihara F.Effects of adrenomedullin on cultured rat cardiac myocytes and fibroblasts[J],1999(1).
  • 6Kitamura K;Kangawa K;Kawamoto M.Adrenomedullin:a novel hypotensive peptide isolated from human pheochromocyteoma[J],1993.
  • 7Nossaman BD;Feng CJ;Cheng DY.Comparative effects of adrenomedullin analog and CGRP in the pulmonary vascular bed of the cat and rat[J],1995.
  • 8Nagaya N;Satoh T;Nishikimi T.Hemodynamic,renal,and hormonal effects of adrenomedullin infusion in patients with congestive heart failure,2000.
  • 9Kano H;Kohno M;Yasunari K.Adrenomedullin as a novel antiproliferative factor of vascular smooth muscle cells[J],1996.
  • 10Ohbayashi H;Suito H;Yoshida N.Adrenomedullin inhibits ovalbumin-induced bronchoconstriction and airway microvascular leakage in guinea-pigs[J],1999.

共引文献9

同被引文献23

引证文献5

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部